OR10J5
gene geneOn this page
Summary
OR10J5 (olfactory receptor family 10 subfamily J member 5, HGNC:14993) is a protein-coding gene on chromosome 1q23.2, encoding Olfactory receptor 10J5 (Q8NHC4). Olfactory receptor.
Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome.
Source: NCBI Gene 127385 — RefSeq curated summary.
At a glance
- GWAS associations: 6
- Clinical variants (ClinVar): 53 total
- MANE Select transcript:
NM_001004469
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:14993 |
| Approved symbol | OR10J5 |
| Name | olfactory receptor family 10 subfamily J member 5 |
| Location | 1q23.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000184155 |
| Ensembl biotype | protein_coding |
| OMIM | 619546 |
| Entrez | 127385 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000334857
RefSeq mRNA: 1 — MANE Select: NM_001004469
NM_001004469
CCDS: CCDS30910
Canonical transcript exons
ENST00000334857 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001336708 | 159535078 | 159536007 |
Expression profiles
Bgee: expression breadth tissue_specific, 3 present calls, max score 81.32.
Top tissues by expression
127 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 81.32 | silver quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 56.32 | gold quality |
| liver | UBERON:0002107 | 43.77 | silver quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| bone marrow cell | CL:0002092 | 36.16 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 35.89 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| muscle tissue | UBERON:0002385 | 32.90 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| bone marrow | UBERON:0002371 | 31.74 | gold quality |
| sural nerve | UBERON:0015488 | 30.93 | gold quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| monocyte | CL:0000576 | 29.68 | gold quality |
| leukocyte | CL:0000738 | 29.49 | gold quality |
| prefrontal cortex | UBERON:0000451 | 29.22 | gold quality |
| duodenum | UBERON:0002114 | 28.14 | gold quality |
| primary visual cortex | UBERON:0002436 | 27.97 | gold quality |
| lymph node | UBERON:0000029 | 27.57 | gold quality |
| tonsil | UBERON:0002372 | 27.05 | gold quality |
| islet of Langerhans | UBERON:0000006 | 26.55 | gold quality |
| vermiform appendix | UBERON:0001154 | 26.42 | gold quality |
| blood | UBERON:0000178 | 26.05 | gold quality |
| gall bladder | UBERON:0002110 | 25.98 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 25.89 | gold quality |
| placenta | UBERON:0001987 | 25.81 | gold quality |
| urinary bladder | UBERON:0001255 | 25.72 | gold quality |
| cortex of kidney | UBERON:0001225 | 25.71 | gold quality |
| muscle of leg | UBERON:0001383 | 24.94 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.31 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): LHX2
Literature-anchored findings (GeneRIF, showing 1)
- data demonstrate the physiological role of OR10J5 in angiogenesis and represent roles of ORs in HUVEC cells (PMID:25791473)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Or10j5 | ENSMUSG00000037924 |
| rattus_norvegicus | Or10j5 | ENSRNOG00000091073 |
Paralogs (130): OR1I1 (ENSG00000094661), OR12D3 (ENSG00000112462), OR7A10 (ENSG00000127515), OR7C2 (ENSG00000127529), OR7C1 (ENSG00000127530), OR1E2 (ENSG00000127780), OR1J1 (ENSG00000136834), OR1L4 (ENSG00000136939), OR4D1 (ENSG00000141194), OR4K1 (ENSG00000155249), OR3A3 (ENSG00000159961), OR7G1 (ENSG00000161807), OR1Q1 (ENSG00000165202), OR1K1 (ENSG00000165204), OR4K2 (ENSG00000165762), OR4D6 (ENSG00000166884), OR1F1 (ENSG00000168124), OR4K14 (ENSG00000169484), OR4K15 (ENSG00000169488), OR7G3 (ENSG00000170920), OR7G2 (ENSG00000170923), OR1M1 (ENSG00000170929), OR4D5 (ENSG00000171014), OR1L6 (ENSG00000171459), OR1L3 (ENSG00000171481), OR1L8 (ENSG00000171496), OR1N2 (ENSG00000171501), OR1N1 (ENSG00000171505), OR2AT4 (ENSG00000171561), OR1A1 (ENSG00000172146), OR1A2 (ENSG00000172150), OR4C11 (ENSG00000172188), OR4X2 (ENSG00000172208), OR4D9 (ENSG00000172742), OR10K1 (ENSG00000173285), OR1L1 (ENSG00000173679), OR7D4 (ENSG00000174667), OR4S2 (ENSG00000174982), OR4B1 (ENSG00000175619), OR4D11 (ENSG00000176200)
Protein
Protein identifiers
Olfactory receptor 10J5 — Q8NHC4 (reviewed: Q8NHC4)
Alternative names: Olfactory receptor OR1-28
All UniProt accessions (2): A0A126GV70, Q8NHC4
UniProt curated annotations — full annotation on UniProt →
Function. Olfactory receptor. Activated by the synthetic floral odorant, lyral, and by alpha-cedrene, a sesquiterpene constituent of cedarwood oil. Its activation increases intracellular Ca(2+). Acts as a key regulator of myogenesis through its actions on cell migration and adhesion by activating the Ca(2+)-dependent AKT signal transduction pathway. Also acts as a regulator of angiogenesis. Moreover, plays a role in the regulation of lipid accumulation in hepatocytes via the cAMP-PKA pathway. May be involved in sperm chemotaxis and motility.
Subcellular location. Cell membrane.
Tissue specificity. Expressed in both the aorta, the coronary artery and umbilical vein endothelial cells (HUVECs) (at protein level).
Similarity. Belongs to the G-protein coupled receptor 1 family.
RefSeq proteins (1): NP_001004469* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000276 | GPCR_Rhodpsn | Family |
| IPR000725 | Olfact_rcpt | Family |
| IPR017452 | GPCR_Rhodpsn_7TM | Domain |
Pfam: PF13853
UniProt features (19 total): topological domain 8, transmembrane region 7, chain 1, glycosylation site 1, disulfide bond 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8NHC4-F1 | 86.04 | 0.49 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (1): 97–188
Glycosylation sites (1): 5
Function
Pathways and Gene Ontology
Reactome pathways
2 pathways
| ID | Pathway |
|---|---|
| R-HSA-381753 | Olfactory Signaling Pathway |
| R-HSA-9752946 | Expression and translocation of olfactory receptors |
MSigDB gene sets: 45 (showing top):
GOBP_SENSORY_PERCEPTION_OF_CHEMICAL_STIMULUS, GOBP_LIPID_HOMEOSTASIS, GOBP_TAXIS, GOBP_MUSCLE_STRUCTURE_DEVELOPMENT, GOBP_REGULATION_OF_MUSCLE_CELL_DIFFERENTIATION, GOBP_BLOOD_VESSEL_MORPHOGENESIS, KEGG_OLFACTORY_TRANSDUCTION, GOBP_DETECTION_OF_STIMULUS, GOBP_SENSORY_PERCEPTION, GOBP_CIRCULATORY_SYSTEM_DEVELOPMENT, GOBP_REGULATION_OF_VASCULATURE_DEVELOPMENT, ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN, GOBP_MUSCLE_CELL_DIFFERENTIATION, GOBP_HOMEOSTATIC_PROCESS, GOBP_CHEMICAL_HOMEOSTASIS
GO Biological Process (11): angiogenesis (GO:0001525), chemotaxis (GO:0006935), G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187), muscle organ development (GO:0007517), sensory perception of smell (GO:0007608), regulation of angiogenesis (GO:0045765), detection of chemical stimulus involved in sensory perception of smell (GO:0050911), regulation of muscle cell differentiation (GO:0051147), lipid homeostasis (GO:0055088), signal transduction (GO:0007165), G protein-coupled receptor signaling pathway (GO:0007186)
GO Molecular Function (2): G protein-coupled receptor activity (GO:0004930), olfactory receptor activity (GO:0004984)
GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-2 pathways:
| Category | Pathways |
|---|---|
| Sensory Perception | 1 |
| Olfactory Signaling Pathway | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| G protein-coupled receptor signaling pathway | 2 |
| transmembrane signaling receptor activity | 2 |
| blood vessel morphogenesis | 1 |
| anatomical structure formation involved in morphogenesis | 1 |
| response to chemical | 1 |
| taxis | 1 |
| animal organ development | 1 |
| muscle structure development | 1 |
| sensory perception of chemical stimulus | 1 |
| angiogenesis | 1 |
| regulation of anatomical structure morphogenesis | 1 |
| regulation of vasculature development | 1 |
| sensory perception of smell | 1 |
| detection of chemical stimulus involved in sensory perception | 1 |
| muscle cell differentiation | 1 |
| regulation of cell differentiation | 1 |
| chemical homeostasis | 1 |
| cell communication | 1 |
| cellular process | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| G protein-coupled receptor activity | 1 |
| signal transduction | 1 |
| detection of chemical stimulus involved in sensory perception of smell | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
200 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| OR10J5 | ADCY3 | O60266 | 509 |
| OR10J5 | GPSM1 | Q86YR5 | 495 |
| OR10J5 | CNGA2 | Q16280 | 461 |
| OR10J5 | OPRM1 | P35372 | 452 |
| OR10J5 | GNG7 | O60262 | 451 |
| OR10J5 | GNAL | P38405 | 413 |
| OR10J5 | A0A140T9Z0 | A0A140T9Z0 | 410 |
| OR10J5 | UGT2A1 | P0DTE4 | 363 |
| OR10J5 | OR2L8 | Q8NGY9 | 362 |
| OR10J5 | TYR | P14679 | 343 |
| OR10J5 | FCER1A | P12319 | 328 |
| OR10J5 | ZNRF2 | Q8NHG8 | 324 |
| OR10J5 | ANKRD44 | Q8N8A2 | 314 |
| OR10J5 | OR6K2 | Q8NGY2 | 307 |
| OR10J5 | PRB3 | Q04118 | 298 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| OR10J5 | PCDHB3 | psi-mi:“MI:0915”(physical association) | 0.400 |
BioGRID (1): PCDHB3 (Affinity Capture-MS)
ESM2 similar proteins: A0A096LPK9, A0A0X1KG70, A6NHA9, A6NMZ5, P0C604, P0C623, P0C645, Q60881, Q62007, Q6IF82, Q8N0Y3, Q8NGA8, Q8NGB4, Q8NGB6, Q8NGC2, Q8NGC6, Q8NGD0, Q8NGD1, Q8NGD2, Q8NGD4, Q8NGE8, Q8NGF8, Q8NGF9, Q8NGI6, Q8NGJ1, Q8NGL6, Q8NGL7, Q8NGL9, Q8NGM1, Q8NGN8, Q8NGS8, Q8NGT0, Q8NH21, Q8NH42, Q8NH43, Q8NH49, Q8NH70, Q8NH72, Q8NH83, Q8NH85
Diamond homologs: A0A3B3IT45, A4D2G3, A6NF89, A6NGY5, A6NL08, A6NL26, A6NMU1, A6NND4, O88628, P0C629, P0C646, P0C7N1, P0C7T3, P23266, P23273, P23274, P30954, Q13606, Q60888, Q62007, Q6IF63, Q6IFG1, Q6W049, Q8NGA6, Q8NGF0, Q8NGF1, Q8NGF3, Q8NGG8, Q8NGH5, Q8NGH6, Q8NGH7, Q8NGH8, Q8NGH9, Q8NGI0, Q8NGI1, Q8NGI2, Q8NGI3, Q8NGI7, Q8NGJ2, Q8NGJ3
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
53 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 51 |
| Likely benign | 1 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
215 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:159535935:T:C | donor_gain | 0.8500 |
| 1:159535337:A:C | acceptor_gain | 0.7900 |
| 1:159535488:C:CT | donor_gain | 0.7900 |
| 1:159535489:T:TT | donor_gain | 0.7900 |
| 1:159535589:AGTC:A | donor_gain | 0.7800 |
| 1:159535945:T:A | donor_gain | 0.7700 |
| 1:159535832:A:C | donor_gain | 0.7600 |
| 1:159535985:T:TA | donor_gain | 0.7600 |
| 1:159535981:CA:C | donor_gain | 0.7400 |
| 1:159535337:A:AC | acceptor_gain | 0.7200 |
| 1:159535330:T:C | acceptor_gain | 0.7000 |
| 1:159535491:CCA:C | donor_gain | 0.7000 |
| 1:159535326:CAATT:C | acceptor_gain | 0.6900 |
| 1:159535492:CAC:C | donor_gain | 0.6900 |
| 1:159535981:CACTT:C | donor_gain | 0.6800 |
| 1:159535315:CTCAG:C | acceptor_gain | 0.6600 |
| 1:159535327:A:T | acceptor_gain | 0.6600 |
| 1:159535868:G:C | donor_gain | 0.6600 |
| 1:159535317:CAG:C | acceptor_gain | 0.6500 |
| 1:159535491:C:CT | donor_gain | 0.6500 |
| 1:159535316:TCA:T | acceptor_gain | 0.6400 |
| 1:159535330:T:TC | acceptor_gain | 0.6200 |
| 1:159535320:C:CC | acceptor_gain | 0.6100 |
| 1:159535357:A:C | acceptor_gain | 0.6100 |
| 1:159535318:AG:A | acceptor_gain | 0.5800 |
| 1:159535346:A:C | acceptor_gain | 0.5800 |
| 1:159535979:G:T | donor_gain | 0.5800 |
| 1:159535316:TCAG:T | acceptor_gain | 0.5700 |
| 1:159535317:CAGC:C | acceptor_gain | 0.5700 |
| 1:159535346:A:AC | acceptor_gain | 0.5700 |
AlphaMissense
2028 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:159535957:A:C | F17L | 0.873 |
| 1:159535957:A:T | F17L | 0.873 |
| 1:159535959:A:G | F17L | 0.873 |
| 1:159535972:G:C | F12L | 0.873 |
| 1:159535972:G:T | F12L | 0.873 |
| 1:159535974:A:G | F12L | 0.873 |
| 1:159535504:G:C | F168L | 0.844 |
| 1:159535504:G:T | F168L | 0.844 |
| 1:159535506:A:G | F168L | 0.844 |
| 1:159535480:G:C | F176L | 0.835 |
| 1:159535480:G:T | F176L | 0.835 |
| 1:159535482:A:G | F176L | 0.835 |
| 1:159535516:G:C | F164L | 0.820 |
| 1:159535516:G:T | F164L | 0.820 |
| 1:159535518:A:G | F164L | 0.820 |
| 1:159535915:G:C | F31L | 0.817 |
| 1:159535915:G:T | F31L | 0.817 |
| 1:159535917:A:G | F31L | 0.817 |
| 1:159535297:A:C | F237L | 0.765 |
| 1:159535297:A:T | F237L | 0.765 |
| 1:159535299:A:G | F237L | 0.765 |
| 1:159535702:G:C | F102L | 0.751 |
| 1:159535702:G:T | F102L | 0.751 |
| 1:159535704:A:G | F102L | 0.751 |
| 1:159535138:A:C | S290R | 0.741 |
| 1:159535138:A:T | S290R | 0.741 |
| 1:159535140:T:G | S290R | 0.741 |
| 1:159535477:A:C | F177L | 0.740 |
| 1:159535477:A:T | F177L | 0.740 |
| 1:159535479:A:G | F177L | 0.740 |
dbSNP variants (sampled 300 via entrez): RS1001513521 (1:159538004 G>GA), RS1003358605 (1:159536903 T>G), RS1006187624 (1:159537850 T>G), RS1007863129 (1:159537454 T>C), RS1008101638 (1:159534886 T>C), RS1008979068 (1:159536996 C>T), RS1010627656 (1:159536607 T>G), RS1011076003 (1:159536882 T>A,C,G), RS1012288718 (1:159535007 G>A,T), RS1014423793 (1:159537934 A>G), RS1015706645 (1:159537355 C>T), RS1015784278 (1:159535743 T>A,G), RS1015879459 (1:159535466 T>C), RS1018239552 (1:159537474 C>A,G,T), RS1018255492 (1:159535779 T>A,G)
Disease associations
OMIM: gene MIM:619546 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
6 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST000080_18 | Hemostatic factors and hematological phenotypes | 2.000000e-07 |
| GCST001650_1 | C-reactive protein | 1.000000e-37 |
| GCST001650_11 | C-reactive protein | 3.000000e-10 |
| GCST001650_8 | C-reactive protein | 4.000000e-73 |
| GCST001762_115 | Obesity-related traits | 6.000000e-06 |
| GCST001762_307 | Obesity-related traits | 1.000000e-21 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004509 | hemoglobin measurement |
| EFO:0004458 | C-reactive protein measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
6 total (human), top 6 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| CGP 52608 | affects binding, increases reaction | 1 |
| bisphenol S | decreases expression, affects cotreatment | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Dexamethasone | affects cotreatment, decreases expression | 1 |
| Indomethacin | affects cotreatment, decreases expression | 1 |
| 1-Methyl-3-isobutylxanthine | affects cotreatment, decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.